ea0025p122 | Diabetes, metabolism and cardiovascular | SFEBES2011
Mooij Christiaan
, Kroese Jeanne Margot
, Sweep Fred
, Hermus Ad
, Tack Cees
Objective: Treatment with glucocorticoids and mineralocorticoids has changed congenital adrenal hyperplasia (CAH) from a fatal to a chronic lifelong disease. As a result of long-term treatment, including chronic (over-)treatment with glucocorticoids, patients with CAH may develop an adverse cardiovascular risk profile. The objective of this study was to evaluate the cardiovascular risk profile of adult CAH patients.Patients and measurements: In this case...